STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin
The FTC is challenging more than 100 patents on brand-name medicines, saying drug companies improperly or inaccurately listed them on a U.S. registry.
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way
